MTS Medication Tech (MPP) Misses Q4 EPS by 1c, Guides for FY08

June 14, 2007 8:31 AM EDT

MTS Medication Technologies (AMEX: MPP) reports Q4 EPS of $0.11, 1 cent worse than estimates. Revenues were $14.3 million vs. $13.92 million consensus.

Revenue associated with consumables and prepack automation sold primarily to the core long-term care market increased 7.9%, OnDemand machine-related revenue increased 92.4% and revenue in Europe increased 161.5%.

For the fiscal year ended March 31, 2008, management anticipates that revenue will range between $61 million and $64 million. (No estimate)

Based upon our revenue expectations and our outlook regarding gross and operating margins, we expect our fully diluted earnings per common share (for FY08) to be in the range of $.52 to $.57. (Consensus is $0.65)

Related Categories

Earnings
Guidance

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?